TY  - GEN
AU  - Park,Won
AU  - Hrycaj,Pawel
AU  - Jeka,Slawomir
AU  - Kovalenko,Volodymyr
AU  - Lysenko,Grygorii
AU  - Miranda,Pedro
AU  - Mikazane,Helena
AU  - Gutierrez-Ureña,Sergio
AU  - Lim,MieJin
AU  - Lee,Yeon-Ah
AU  - Lee,Sang Joon
AU  - Kim,HoUng
AU  - Yoo,Dae Hyun
AU  - Braun,Jürgen
TI  - A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
SN  - 1468-2060
PY  - 2013///1126
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibody Formation
KW  - Antirheumatic Agents
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Immunoglobulin G
KW  - Infliximab
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Severity of Illness Index
KW  - Spondylitis, Ankylosing
KW  - blood
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/annrheumdis-2012-203091
ER  -